Americold explores sale or IPO: WSJ

By Luisa Beltran — 1 week ago

Americold, backed by billionaire West Coast investor Ron Burkle, is exploring a sale or IPO, the Wall Street Journal reported. Americold, which owns temperature-controlled warehouses, could be valued at more than $3 billion, or even $4 billion, the story said. The company is working with bankers to sound out interested parties while also considering a listing. Americold is a real-estate investment trust owned by Yucaipa Cos; it shelved a prior IPO attempt in 2010.

Continue

VC-backed Argenx goes public

By Iris Dorbian — 2 weeks ago

Argenx, a Dutch developer of antibodies that treat cancer and severe autoimmune diseases, has raised about $100 million for its IPO after pricing its 5.9 million shares at $17 per share. The stock began trading May 18, 2017 on the NASDAQ under the ticker symbol “ARGX.” Cowen and Company and Piper Jaffray & Co. are serving as the lead underwriters. Argenx’s backers include Aquila Capital, Forbion Capital Partners, OrbiMed, MPM Capital and Seventure Partners, according to Crunchbase. Currently, Argenx is trading on Euronext Brussels.

Continue

VC-backed Argenx hikes up IPO offering to five million shares

By Iris Dorbian — 2 weeks ago

Argenx, a Dutch developer of antibodies that treat cancer and severe autoimmune diseases, has increased its IPO offering to five million shares. The stock will trade on the NASDAQ under the ticker symbol “ARGX.” Cowen and Company and Piper Jaffray & Co. are serving as the lead underwriters. Argenx’s backers include Aquila Capital, Forbion Capital Partners, OrbiMed, MPM Capital and Seventure Partners, according to Crunchbase. Currently, Argenx is trading on Euronext Brussels.

Continue

Legion Capital sets IPO pricing terms

By Iris Dorbian — 2 weeks ago

Private equity firm Legion Capital Corporation has priced its IPO of 4 million shares at $1.25 per share. The company is planning on listing the stock on the NASDAQ. J. Bradley Hilton, grandson of fabled hotelier Conrad Hilton, leads Legion Capital.

Continue

Pret A Manger considers IPO: Bloomberg

By Luisa Beltran — 3 weeks ago

Pret A Manger, the sandwich chain, is considering going public, according to Bloomberg. Pret, which is backed by Bridgeport Advisers, is working with several banks, including Credit Suisse, Barclays, JPMorgan & Chase, Piper Jaffray and Jefferies.

Continue

PE-backed Advantage Solutions to go public

By Iris Dorbian — 4 weeks ago

Irvine, California-based Advantage Solutions Inc, a business solutions provider, has filed for an IPO. the number of shares that will be sold as well as the stock’s pricing terms have yet to be set. Goldman Sachs and Morgan Stanley are the lead underwriters. Advantage is backed by CVC Capital Partners and Leonard Green & Partners.

Continue

Yorktown Partners-backed Solaris sets IPO pricing terms

By Iris Dorbian — 4 weeks ago

Solaris Oilfield Infrastructure, which is backed by Yorktown Partners, has priced its IPO of 10.6 million shares at between $15 and $18 per share. The stock will trade on the New York Stock Exchange under the ticker symbol “SOI.” Credit Suisse and Goldman Sachs are serving as the lead underwriters. Based in Houston, Texas, Solaris is a provider of patented mobile proppant management systems that unload, store and deliver proppant at oil and natural gas well sites.

Continue

VC-backed Zymeworks rolls out New York and Toronto IPO

By Iris Dorbian — 1 month ago

Vancouver, British Columbia-based biotherapeutics provider Zymeworks Inc has raised $58.5 million for its IPO after pricing its 4.5 million shares at $13 per share. The stock began trading April 28, 2017 on the New York Stock Exchange and on the Toronto Stock Exchange under the ticker symbol “ZYME.”Citigroup Global Markets Canada Inc., Barclays Capital Inc. and Wells Fargo Securities, LLC are the lead underwriters. Zymeworks’ pre-IPO backers include BDC Capital, Lumira Capital, CTI Life Sciences Fund, Fonds de solidarité FTQ, Perceptive Advisors, Teralys Capital, Northleaf Venture Catalyst Fund, Brace Pharma Capital and Merlin Nexus.

Continue

PE-backed NCS unveils IPO

By Iris Dorbian — 1 month ago

Houston, Texas and Calgary-based NCS Multistage Holdings, a technology and services company specializing in multistage completions, has raised $161.5 million for its IPO after pricing its 9.5 million shares at $17 per share. The stock began trading April 28, 2017 on the NASDAQ under the ticker symbol “NCSM.” Credit Suisse, Citigroup and Wells Fargo Securities are serving as the lead underwriters. NCS is backed by Advent International.

Continue